Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 7Prostatic Neoplasms 5Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Stomach Neoplasms 2Rectal Neoplasms 2Polycystic Ovary Syndrome 2Peripheral Nervous System Diseases 2Neoplasms 2Multiple Myeloma 2Agnosia 2Urinary Bladder Neoplasms 1Tooth, Impacted 1Small Cell Lung Carcinoma 1Signs and Symptoms 1Sepsis 1Sarcoma 1Resectable Colorectal Carcinoma 1Recurrence 1Postoperative Urinary Retention (POUR) 1Pancreatic Neoplasms 1Nocturia 1Myasthenia Gravis 1Menstruation Disturbances 1Lymphoma, Non-Hodgkin 1Lymphoma 1Insulin Resistance 1Hot Flashes 1Hodgkin Disease 1Gastrointestinal Neoplasms 1

Interventions

Metformin 21Inositol 13Letrozole 9Exercise 5Surveys and Questionnaires 4Clomiphene 4Tablets 3Estradiol 3semaglutide 2maltodextrin 2drospirenone and ethinyl estradiol combination 2Spironolactone 2Progesterone 2Ethinyl Estradiol 2Diet Therapy 2Contraceptives, Oral, Combined 2Caloric Restriction 2Acupuncture Therapy 2salicylsalicylic acid 1mirabegron 1etonogestrel 1drospirenone 1dapagliflozin 1cetrorelix 1Walking 1Tirzepatide 1Thyroxine 1Thioctic Acid 1Tamoxifen 1Sodium-Glucose Transporter 2 Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Polycystic Ovary Syndrome × Acupuncture Therapy × 1 year × Clear all
NCT03625531 2026-04-14

A Trial of Personalized Acupuncture, Fixed Acupuncture, Letrozole and Placebo on Live Birth in Women With PCOS

The First Affiliated Hospital of Guangzhou Medical University

Phase 3 Completed
1,103 enrolled

Polycystic Ovary Syndrome

NCT06306417 2025-06-22

A Randomized Controlled Trial of Acupuncture for Insulin Resistance in Patients With Polycystic Ovary Syndrome

Peking University Third Hospital

Phase NA Completed
144 enrolled

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡